Filter
770
Text search:
J.
Liu
Featured
Recommendations
67
New Publications
75
Language
Document type
No document type
262
Studies & Reports
206
Guidelines
189
Manuals
45
Fact sheets
37
Strategic & Response Plan
15
Training Material
6
Infographics
5
Situation Updates
4
Brochures
1
Countries / Regions
Russia
32
Global
30
Brazil
24
India
15
Middle East and North Africa
14
Western and Central Europe
14
Germany
13
Ethiopia
12
Syria
12
Latin America and the Carribbean
12
Kenya
11
Eastern Europe
11
Yemen
10
Peru
9
Asia
9
South Africa
8
Mozambique
8
Africa
8
Spain
8
Nigeria
7
Angola
7
Senegal
6
Uganda
6
Indonesia
6
Malawi
6
West and Central Africa
6
Sierra Leone
5
Guinea-Bissau
5
Nepal
5
Bangladesh
5
Ukraine
5
Ecuador
5
Vietnam
5
Burkina Faso
4
Mali
4
Ghana
4
Somalia
4
Tanzania
4
Sudan
4
Argentina
4
Colombia
4
Chile
4
East and Southern Africa
4
Eastern Europe and Central Asia
4
France
4
Guinea
3
Liberia
3
Congo, Democratic Republic of
3
Cameroon
3
Haiti
3
Philippines
3
South Sudan
3
South–East Asia Region
3
Western Pacific Region
3
Venezuela
3
Italy
3
Saudi Arabia
2
Niger
2
Lebanon
2
Zambia
2
Chad
2
Cambodia
2
Thailand
2
China
2
Rwanda
2
Benin
2
Bolivia
2
Lesotho
2
Myanmar / Burma
2
Laos
2
North America
2
Portugal
2
Belarus
2
Côte d’Ivoire / Ivory Coast
1
Morocco
1
USA
1
Pakistan
1
Iraq
1
Jordan
1
Afghanistan
1
Turkey
1
Egypt
1
Malaysia
1
Mauritania
1
Dominican Republic
1
North Macedonia
1
Austria
1
Switzerland
1
Cuba
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Madagascar
1
Mexico
1
Nicaragua
1
Sri Lanka
1
Paraguay
1
Armenia
1
Congo-Brazzaville
1
Canada
1
Qatar
1
Kazakhstan
1
Georgia
1
Belgium
1
Tunisia
1
United Kingdom
1
Israel
1
Latvia
1
Authors & Publishers
Publication Years
Category
Countries
241
Clinical Guidelines
58
Public Health
50
Women & Child Health
28
Key Resources
11
Capacity Building
4
Pharmacy & Technologies
4
General Guidelines
1
Toolboxes
COVID-19
233
Mental Health
77
Planetary Health
65
HIV
59
TB
41
NCDs
30
AMR
19
Caregiver
19
Disability
15
Pharmacy
14
Global Health Education
12
NTDs
12
Rapid Response
10
Ebola
7
Natural Hazards
6
Conflict
4
Zika
4
Health Financing Toolbox
3
Refugee
2
Polio
1
Specific Hazards
1
Social Ethics
1
This document updates the earlier version published in April 2020. In recent weeks, information on the potential use of chloroquine or hydroxychloroquine for the treatment of people with COVID-19 has been disseminated in academic journals and public media. Although there are now ongoing clinical tri
...
Scientific Brief, 30 June 2020
Настоящее руководство «Клиническое ведение случаев COVID-19» базируется на
вышеуказанных стратегических приоритетах и адресовано клиницистам, участвующим в
оказа
...
Updated 10 August 2020
This document presents an essential medicines list (EML) to manage patients in intensive care units (ICUs) with suspected or confirmed COVID-19 diagnosis, which includes active ingredients with dosage form and concentration, and are preferably in the WHO Model Lists of Essent
...
24 marzo 2020
El objetivo de este documento es elaborar una lista de medicamentos esenciales para manejar los pacientes en unidades de cuidados intensivos con sospecha o diagnóstico confirmado de COVID -19. Incluye principios activos con su forma farmacéutica y concentración —preferentemente e
...
Le présent document est une mise à jour du document d’information scientifique publié le 29 mars 2020 intitulé Modes of transmission of virus causing COVID-19: implications for infection prevention and control (IPC) precaution recommendations et comprend les nouvelles don
...
-Covid-19 и беременность
-Особенности применения методов диагностики у беременных
-Особенности лечения covid-19 при беременности
-Акушерская тактика при covid-19
-Маршрути
...
В настоящем документе представлен первоначальный обзор поступающей информации
(по состоянию на 2 июля 2020 г.) о взаимосвязи между COVID-19, НИЗ и факторами
риска НИЗ. Ре
...
Nota INformatIva Nº 13/2020 - SE/GaB/SE/mS
September 2020
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man
...
orientaciones provisionales, 8 de noviembre de 2020
This interim guidance is most useful for countries interested in monitoring relative circulations of influenza and SARS-CoV-2 viruses. The document provides practical information to maintain surveillance of influenza and monitor SARS-CoV-2 using e
...
COVID-19 infection affects all age groups including newborns, however, literature is scarce on the fetal and neonatal outcomes of babies exposed in-utero, especially in Africa. The objectiveof this study was to document the perinatal outcomes of COVID-19 pregnancies and del
...
Scientific Brief, 17 June 2021
Modelling the health impacts of disruptions to essential health services during COVID-19 Module 1
Several epidemiological models have been created to assess the potential impact of disruptions to essential health services caused by COVID-19 on morbidity and mortality from conditions other than COVI
...
15 July 2021. This report describes the demographics, clinical presentation, clinical outcomes, and risk factors among people living with HIV (PLHIV) who have been hospitalized for suspected or confirmed COVID-19.
The specific objectives of the analysis were to:
describe the clinical char
...
In order to meet changing global population needs and consumer expectations, healthcare systems worldwide are under transformation and face restructuring. As systems adapt and shift their emphasis in response to the disparate requests for healthcare services, oppor-tunities emerge for nurses, especi
...
- Module 1: Understanding modelling approaches for sexual, reproductive, maternal, newborn, child and adolescent health, and nutrition
Coronavirus disease 2019 (COVID-19) has a wide range of documented effects. It directly causes death and disability for some people infected. However, disruption to
...
Note d’information scientifique, 17 juin 2021
La presente publicación describe la evidencia científica publicada respecto a la hipertensión como factor pronóstico en pacientes con COVID-19. Se identificó una revisión sistemática que evaluó diferentes desenlaces de pronóstico en pacientes con hipertensión y diagnóstico confirmado de C
...
La presente publicación describe la evidencia científica disponible sobre la utilidad del uso complementario de pruebas moleculares y de detección de anticuerpos para mejorar el diagnóstico de sospechosos de COVID-19. La utilización complementaria de ambas pruebas podría mejorar la identificac
...